Impact of a hospital-wide antimicrobial formulary intervention on the incidence of multidrug-resistant gram-negative bacteria

American Journal of Infection Control

Volumn 36, Issue 9, 2008, Pages 661-664

  Furtado, Guilherme H C ^a,b   Perdiz, Luciana B ^b   Santana, Iolanda Lopes ^a   Camargo, Márcia M S C R ^a   Parreira, Fernanda C ^b   Angelieri, Daniela B ^b   Medeiros, Eduardo A S ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Division of Infectious Diseases   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFEPIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; LINEZOLID; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ARTICLE; CONTROLLED STUDY; DRUG USE; ENTEROBACTER; GRAM NEGATIVE BACTERIUM; HOSPITAL CARE; KLEBSIELLA PNEUMONIAE; MULTIDRUG RESISTANCE; NONHUMAN; TERTIARY HEALTH CARE;

ANTI-BACTERIAL AGENTS; BRAZIL; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALS; HUMANS; INCIDENCE;

EID: 55049088261     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2007.11.014     Document Type: Article

References (10)

1. Schwartz B., Bell D.M., and Hughes J.M. Preventing the emergence of antimicrobial resistance: a call for action by clinicians, public health officials, and patients. JAMA 278 (1997) 944-945
2. Sader H.S., Jones R.N., Andrade-Baiocchi S., and Biedenbach D.J. Sentry Participants Group (Latin America). Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers. Diagn Microbiol Infect Dis 44 (2002) 273-280
3. Paterson D.L., Ko W.C., Von Gottberg A., Mohapatra S., Casellos J.M., and Goossens H. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum β-lactamase production in nosocomial infections. Ann Intern Med 140 (2004) 26-32
4. Bisson G., Fishman N.O., Patel J.B., Edelstein P.H., and Lautenbach E. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence. Infect Control Hosp Epidemiol 23 (2002) 254-260
5. Patterson J.E., Hardin T.C., Kelly C.A., Garcia R.C., and Jorgensen J.H. Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae. Infect Control Hosp Epidemiol 21 (2000) 455-458
6. Lipworth A.D., Hyle E.P., Fishman N.O., Nachamkin I., Bilker W.B., Marr A.M., et al. Limiting the emergence of extended-spectrum β-lactamase-producing enterobacteriaceae: influence of patient population characteristics on the response to antimicrobial formulary interventions. Infect Control Hosp Epidemiol 27 (2006) 279-286
7. Go E., Urban C., Burns J., Kreiswirth B., Eisner W., and Mariano N. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet 344 (1994) 1329-1332
8. Rice L.B., Eckstein E.C., DeVente J., and Shlaes D.M. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 23 (1996) 118-124
9. Bantar C., Sartori B., Vesco E., Heft C., Saul M., Salamone F., et al. A hospital-wide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance. Clin Infect Dis 37 (2003) 180-186
10. Rahal J.J., Urban C., Horn D., Freeman K., Segal-Mauer S., and Mauer J. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 280 (1998) 1233-1237